Zevra Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ZVRA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
11 Oct 24	BuyUS$3,958	Corey Watton	Individual	500	US$7.92
17 Jul 24	BuyUS$13,540	R. Clifton	Individual	2,000	US$6.77
16 Jul 24	BuyUS$68,065	Thomas Anderson	Individual	10,000	US$6.81
12 Jul 24	BuyUS$58,661	John Bode	Individual	10,000	US$5.87

Insider Trading Volume

Insider Buying: ZVRA insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ZVRA?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	20,858	0.0391%
Individual Insiders	3,298,323	6.18%
Hedge Funds	6,972,674	13.1%
General Public	20,821,518	39%
Institutions	22,262,559	41.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.7%.

Top Shareholders

Top 25 shareholders own 54.76% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.59%	Woodline Partners LP	4,048,653	US$34.0m	253%	0.3%
5.85%	BlackRock, Inc.	3,121,759	US$26.2m	15.8%	no data
5.66%	Samuel Braun	3,021,660	US$25.4m	0%	no data
5.48%	Nantahala Capital Management, LLC	2,924,021	US$24.5m	20.9%	1.83%
5.16%	The Vanguard Group, Inc.	2,756,061	US$23.1m	50.3%	no data
4.33%	FMR LLC	2,313,166	US$19.4m	301,000%	no data
3.18%	Altium Capital Management LP	1,700,000	US$14.3m	46.3%	4.52%
2.3%	683 Capital Management, LLC	1,225,000	US$10.3m	53.1%	1.06%
1.96%	Geode Capital Management, LLC	1,043,864	US$8.8m	14.2%	no data
1.84%	J. Goldman & Co., L.P.	984,182	US$8.3m	0%	0.34%
1.45%	State Street Global Advisors, Inc.	772,825	US$6.5m	7.36%	no data
1.31%	Stonepine Capital Management LLC	700,000	US$5.9m	0%	2.1%
1.22%	Adage Capital Management, L.P.	649,000	US$5.4m	0%	0.01%
0.98%	Vestal Point Capital, LP	525,000	US$4.4m	0%	0.35%
0.94%	The Retirement Planning Company of New England, Inc.	499,505	US$4.2m	8.99%	2.04%
0.78%	Stratos Wealth Partners, Ltd	418,640	US$3.5m	496%	0.05%
0.72%	ExodusPoint Capital Management, LP	386,245	US$3.2m	0%	0.03%
0.66%	Northern Trust Global Investments	354,720	US$3.0m	20.9%	no data
0.66%	Silverarc Capital Management, LLC	350,000	US$2.9m	0%	0.69%
0.58%	Mystic Asset Management, Inc.	307,447	US$2.6m	3.19%	0.95%
0.57%	Janney Montgomery Scott LLC, Asset Management Arm	305,069	US$2.6m	-29.5%	0.01%
0.43%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	227,164	US$1.9m	75.1%	no data
0.4%	Susquehanna International Group, LLP, Asset Management Arm	214,798	US$1.8m	55.1%	no data
0.37%	Velan Capital Partners LP	200,000	US$1.7m	0%	1.6%
0.34%	Propel Bio Management, LLC	179,874	US$1.5m	0%	1.47%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 04:54
End of Day Share Price	2024/12/30 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zevra Therapeutics, Inc. is covered by 16 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Dewey Steadman	Canaccord Genuity
Sumant Satchidanand Kulkarni	Canaccord Genuity
Louise Chen	Cantor Fitzgerald & Co.